Related Links
Nucleoside Reverse Transcriptase Inhibitors (NRTI's)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI's)
Protease Inhibitors (PI)
Fusion Inhibitors (FI's)
Updated:
As this is the NEW website for the AIDS Committee of Windsor, AIDS Support Chatham-Kent, and the Drouillard Road Clinic, everything is new and in the process of being updated. If by chance there is anything wrong with the information, feel free to contact us.

Treatment Information
Ziagen (Abacavir sulfate)
Abacavir (also known as GW1592) is an anti-HIV drug approved for the treatment of HIV infection in children and adults. Results from a number of studies suggest that abacavir is most effective when used as part of a triple combination therapy regimen with two other anti-HIV drugs.
Abacavir is a nucleoside analogue, which means that it works by obstructing the building blocks of genetic material (e.g., RNA or DNA) from being assembled together and therefore inhibits the virus from reproducing. Although abacavir appears to impair HIV's ability to replicate, it will never be a cure for AIDS since it does not totally eradicate HIV from the body.
Pregnant Women & Abacavir
Abacavir has not been formally studied in pregnant women. Women should be cautious of breast feeding while taking abacavir because it may be passed through breast milk resulting in potential toxicity to the child. Studies of abacavir in children are ongoing and it is expected to have similar results to those seen to date in the adult studies.
What about side effects?
The most common side effects reported in the clinical studies are nausea, fatigue, headaches and diarrhea. A more serious side effect which affects about 3% of people taking abacavir is a hypersensitivity reaction to the drug. This reaction is usually systemic (throughout the body) and includes fevers, malaise, nausea, vomiting and sometimes rash. This reaction appears relatively soon after starting abacavir (about two weeks) and resolves one or two days after stopping the drug. It is important not to try and take abacavir again (re-challenge) if there was hypersensitivity to the drug as the subsequent reaction is potentially fatal.
How to Use it
Dosing
Food Interactions
Where to Get It?
HIV & the Brain
Because HIV can infect brain cells, it's important to consider a drug's ability to reach the brain when putting together an anti-HIV regimen. It's probably wise to include at least one drug that has been shown to cross the blood-brain barrier to some useful degree as part of your regimen. These include AZT (zidovudine, Retrovir), d4T (stavudine, Zerit), abacavir (Ziagen), nevirapine (Viramune), amprenavir (Agenerase) and to a lesser degree indinavir (Crixivan) and 3TC (lamivudine, Epivir). Efavirenz (Sustiva) has not been shown to cross the barrier to a significant degree, but some experts speculate that it might have some useful effect in impacting HIV in the spinal fluid.
Note:
This information was provided by the Community AIDS Treatment Information Exchange (CATIE). For more information, contact CATIE at 1-800-263-1638.
